![Raf Roelands](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raf Roelands
Direktor/Vorstandsmitglied bei
Ontoforce NV
Profil
Raf Roelands is currently Director at Ontoforce NV, Director at MRM Health NV since 2020, Director at Hypervision Surgical Ltd. since 2023, and Partner at Heran Partners BV.
Former positions include Director at reMYND NV and Senior Investment Manager at Korys Management NV from 2021 to 2022.
Education includes graduate degrees from Vlerick Leuven Gent Management School in 2016 and Katholieke Universiteit Leuven in 2009.
Aktive Positionen von Raf Roelands
| Unternehmen | Position | Beginn |
|---|---|---|
Ontoforce NV
 Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Direktor/Vorstandsmitglied | - |
MRM Health NV
 MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Direktor/Vorstandsmitglied | 01.02.2020 |
Hypervision Surgical Ltd.
 Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Direktor/Vorstandsmitglied | 01.06.2023 |
Heran Partners BVBA
 Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Raf Roelands
| Unternehmen | Position | Ende |
|---|---|---|
Korys Management NV
 Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Private-Equity-Analyst | 01.06.2019 |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Direktor/Vorstandsmitglied | - |
Ausbildung von Raf Roelands
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Korys Management NV
Korys Management NV Investment ManagersFinance Korys invests in companies located in Belgium. The firm focuses on conscious consumer, energy transition and healthy living sectors. It participates in buyout and early stage transactions with an investment size of EUR 5 - 15 million. The firm also makes investment in private equity funds. | Finance |
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vlerick Leuven Gent Management School
 Vlerick Leuven Gent Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
Ontoforce NV
Ontoforce NV Packaged SoftwareTechnology Services Creates and implements pioneering technology for information flow and management | Technology Services |
Heran Partners BVBA
Heran Partners BVBA Investment ManagersFinance Heran Partners invests in private companies located in Europe. The firm focuses on the health technology sector. It participates in seed stage, early stage and growth stage transactions with an investment size of EUR 5 - 50 million. The firm acquires minority and majority interests and makes co-investments. | Finance |
MRM Health NV
MRM Health NV BiotechnologyHealth Technology Operates biopharmaceutical company that focuses on the discovery and development of innovative therapeutics based on the human micro biome | Health Technology |
Hypervision Surgical Ltd.
Hypervision Surgical Ltd. Packaged SoftwareTechnology Services Provides AI-powered spectral imaging services of surgeries | Technology Services |
